Treatment resistant depression in the UK: sub-analysis of a European real-world evidence study

被引：1
|
作者：
Talbot, Jordan [1 ]
MacIntyre, Donald J. [2 ]
Rathod, Shanaya [3 ]
Morrens, Joachim [4 ]
Young, Allan H. [5 ,6 ]
机构：
[1] Janssen UK, High Wycombe, Bucks, England
[2] Univ Edinburgh, Div Psychiat, Royal Edinburgh Hosp, Kennedy Tower, Edinburgh, Midlothian, Scotland
[3] Southern Hlth NHS Fdn Trust, Res Dept, Tom Rudd Unit, Southampton, Hants, England
[4] Janssen EMEA, Beerse, Belgium
[5] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England
[6] Bethlem Royal & Maudsley Hosp, South London & Maudsley NHS Fdn Trust, Beckenham, Kent, England
来源：
BJPSYCH OPEN | 2021年 / 7卷
关键词：
D O I：
10.1192/bjo.2021.192
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [31] A Real-World Study on the Use, Effectiveness, and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression: INTEGRATE Study
    Molero, Patricio
    Ibanez, Angela
    de Diego-Adelino, Javier
    Ramos-Quiroga, J. Antoni
    Garcia Dorado, Marta
    Lopez Rengel, Paola M.
    Saiz, Pilar A.
    ADVANCES IN THERAPY, 2025, : 2335 - 2353
  • [32] TREATMENT RESPONSE WITH ABATACEPT PLUS METHOTREXATE TREATMENT FOR RHEUMATOID ARTHRITIS: REAL-WORLD EVIDENCE FROM THE UK
    Choy, E.
    Henning, S.
    Brazil, M.
    Pollock, K.
    Groves, L.
    Sugrue, D.
    Houghton, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1299 - 1299
  • [33] Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-longz retrospective data analysis
    Rihmer, Z.
    EUROPEAN PSYCHIATRY, 2022, 65 : S41 - S41
  • [34] Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-long retrospective data analysis
    Doeme, Peter
    Kunovszki, Peter
    Takacs, Peter
    Feher, Laszlo
    Balazs, Tamas
    Dede, Karoly
    Mulhern-Haughey, Siobhan
    Barbreau, Sebastien
    Rihmer, Zoltan
    PLOS ONE, 2021, 16 (01):
  • [35] Real-world evidence on fremanezumab for migraine treatment in Japan: a retrospective analysis
    Takizawa, T.
    Ohtani, S.
    Watanabe, N.
    Ihara, K.
    Takahashi, N.
    Miyazaki, N.
    Ishizuchi, K.
    Takemura, R.
    Hori, S.
    Nakahara, J.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [36] Real-world evidence of galcanezumab for migraine treatment in Japan: A retrospective analysis
    Takizawa, T.
    Ohtani, S.
    Watanabe, N.
    Miyazaki, N.
    Ishizuchi, K.
    Sekiguchi, K.
    Iba, C.
    Shibata, M.
    Takemura, R.
    Hori, S.
    Nakahara, J.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [37] Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis
    Tsubasa Takizawa
    Seiya Ohtani
    Narumi Watanabe
    Naoki Miyazaki
    Kei Ishizuchi
    Koji Sekiguchi
    Chisato Iba
    Mamoru Shibata
    Ryo Takemura
    Satoko Hori
    Jin Nakahara
    BMC Neurology, 22
  • [38] Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis
    Takizawa, Tsubasa
    Ohtani, Seiya
    Watanabe, Narumi
    Miyazaki, Naoki
    Ishizuchi, Kei
    Sekiguchi, Koji
    Iba, Chisato
    Shibata, Mamoru
    Takemura, Ryo
    Hori, Satoko
    Nakahara, Jin
    BMC NEUROLOGY, 2022, 22 (01)
  • [39] Botulinum Toxin as a Treatment for Depression in a Real-world Setting
    Chugh, Sanjay
    Chhabria, Anjali
    Jung, Stefanie
    Kruger, Tillmann H. C.
    Wollmer, M. Axel
    JOURNAL OF PSYCHIATRIC PRACTICE, 2018, 24 (01) : 15 - 20
  • [40] Real-world evidence data on aRCC treatment in Austria: the RELACS study
    Schmidinger, M.
    Pichler, R.
    Bauernhofer, T.
    Kretz, M.
    Tinchon, C.
    Niedersuess-Beke, D.
    Pfleger, G.
    Heinrich, E.
    Vogl, U.
    Mitterberger, M.
    Stoeger, H.
    Tulchiner, G.
    Kratochvill, F.
    Mraz, B.
    Marszalek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 276 - 276
12345